FeesSafety
Pluang+

SPX Technologies posts strong Q3 revenue but shares drop on margin and guidance concerns

Company Fundamentals
03 Nov 2026, 13:41 WIB
Seeking Alpha
View Source
Neutral
SPX Technologies posts strong Q3 revenue but shares drop on margin and guidance concerns

SPX Technologies reported strong revenue and asset growth in Q3 2026, driven by robust demand in data-center cooling and geographic expansion. However, shares fell due to margin compression in the HVAC segment and a lowered EBITDA guidance for 2026. Despite near-term challenges, the company's medium- and long-term outlook remains positive with growing backlogs and fair valuation near sector medians. The analyst maintains a Buy rating, seeing undervalued long-term growth potential in data-center cooling and expansion opportunities.

SPX Technologies faces mixed market signals following its Q3 earnings report. For readers following Industrials-sector stocks, here is Pluang's market snapshot as of Nov 03, 2026 17:41 WIB: out of 135 priced stocks, 72 rose and 53 fell. Notable movers include EOSE at USD 1.80 (+2.27%, 20% Sell / 80% Buy, typical hold time 18 days), BWXT at USD 127.81 (-2.04%, typical hold time 19 days), and RKLB at USD 53.12 (+2.02%, 47% Sell / 53% Buy, typical hold time 33 days).

More News

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
2 hours ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
2 hours ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
2 hours ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
3 hours ago
Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App